Groundbreaking animal wellness company PetVivo Holdings Inc., an emerging bio-medical company, announces the formation of nonprofit PetVivo Cares

Nonprofit PetVivo Cares mission is to help extend the life of service animals by providing animal nonprofits with a revolutionary osteoarthritis treatment called Kush ™ 


MINNEAPOLIS, Dec. 11, 2018 (GLOBE NEWSWIRE) -- OTCPINK: PETV PetVivo Holdings, Inc. (www.petvivo.com) announced today the formation of a new nonprofit called PetVivo Cares whose mission is to help extend the lives of services animals. Currently registered as a 371 A organization in the State of Minnesota, PetVivo Cares is in the process of filing its 501c3 status for federal exempt recognition, and anticipates receiving its IRS determination in early 2019.

PetVivo Cares will operate as separate entity from PetVivo Holdings Inc. an emerging bio medical company who developed a lameness treatment for horses and dogs called Kush ™. The treatment involves injecting the “Kush” into the joint of a horse or canine suffering from Osteoarthritis. The treatment provides a “cushion” that relieves and alleviates the pain in the joint of the animal. The Kush™ treatment has already been proven successful in the treatment of osteoarthritis in horses and service animals across America. One of the first organizations that will be receiving our KUSH particles will be Guardian Angel Medical Service Dogs. Carol Borden commented on the relationship with PetVivo Cares "We are very excited to partner with Petvivo. Our mission is to help those with disabilities through the amazing skills of our service dogs. We follow our teams and support them for life. We strive to maintain the service dog's working ability as long as possible, which sometimes ends too soon without viable solutions for geriatric conditions such as arthritis or spondylosis, etc. Petvivo gives us that solution. Together We Can Unleash The Power To Heal."

The mission of nonprofit PetVivo Cares will be to provide grants of free or reduced cost PetVivo Kush™ treatments to other nonprofit animal care organizations. Treatments of Kush™ will be administered by licensed veterinarians, and made available to nonprofit animal rescue shelters, as well as horses and canines currently in the service of law enforcement, the military or persons with disabilities. 

A limited number of Kush ™ treatments will be donated annually to PetVivo Cares, by PetVivo Holdings, Inc. The donated product will be made available to USA based animal care nonprofits via PetVivo Cares, on a need or ability to pay basis.     

“PetVivo Cares is excited to work with other great animal nonprofit organizations to improve the quality of life of service dogs and horses,” said John Lai President of PetVivo Holdings, Inc. “Our Kush™ treatment will allow service animals to provide aid and comfort to their owners much longer.” 

For more information about PetVivo Cares please contact info1@petvivo.com or visit https://petvivo.com/

About PetVivo Holdings, Inc.

PetVivo Holdings Inc. (OTCPINK: PETV) is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets and pet therapeutics. PetVivo is leveraging investments made in the human medical device industry to commercialize therapeutics for pets in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals.

PetVivo's strategy is to commercialize proprietary products from human medical device companies specifically for the companion animal market. The company’s product pipeline includes seventeen animal and human therapeutics. A portfolio of twenty patents protects the company’s products, production processes and biomaterials. PetVivo’s lead product, a veterinarian-administered joint injection for the treatment of osteoarthritis in dogs, is scheduled for launch later this year.   

Forward-Looking commercial Statements:

The foregoing material may contain forward-looking statements. We caution that such statements may be subject to uncertainties and that actual results could differ materially from the forward-looking statements. Readers accordingly should not place undue reliance on these forward-looking statements, which do not reflect unknown or unanticipated events or circumstances occurring after the date of these forward-looking statements

CONTACT:
John Lai
President
PetVivo Holdings, Inc.
Main: 962-405-6216